日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

METCAM/MUC18 is a Biomarker and Therapeutic Target for Prostate Cancer.

METCAM/MUC18 是前列腺癌的生物标志物和治疗靶点。

Wu Guang-Jer, Hsieh Chia-Chi, Fu Yan-Cheng, Chuang Yin-Huan, Wei Yu-Chun, Pong Yuan-Hung, Su Yenn-Rong, Tsai Vincent F-S, Wu Jui-Chuang

Comparing Cancer Risks and Mortality between Phytopharmaceuticals and Estrogen-Progestogen Medications for Menopausal Women: A Population-Based Cohort Study

比较植物药与雌激素-孕激素类药物对更年期女性癌症风险和死亡率的影响:一项基于人群的队列研究

Lin, Tsai-Bei; Hsieh, Chia-Chi; Wang, Chun-Hsiang; Chang, Chiung-Hung; Hsueh, Yu-Ling; Tseng, Yuan-Tsung; Hsieh, Men-Fong

Protocol for efficient human MSC chondrogenesis via Wnt antagonism instead of TGF-β

通过 Wnt 拮抗剂替代 TGF-β 实现高效人类 MSC 软骨形成的方案

Chen-Chan Hsieh, Chia-Chi Chang, Pei-Ju Hsu, Linyi Chen, B Linju Yen

METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay

METCAM/MUC18 是一种用于前列腺癌恶性潜能早期诊断的新型生物标志物:采用蛋白质印迹法、酶联免疫吸附试验和侧向层析免疫分析法进行验证

Pong, Yuan-Hung; Su, Yann-Rong; Lo, Hsing-Wen; Ho, Chung-Kun; Hsieh, Chia-Chi; Chu, Ching-Tung; Chen-Yang, Yui Whei; Tsai, Vincent F S; Wu, Jui-Chuang; Wu, Guang-Jer

TDAG8, TRPV1, and ASIC3 involved in establishing hyperalgesic priming in experimental rheumatoid arthritis

TDAG8、TRPV1 和 ASIC3 参与建立实验性类风湿关节炎的痛觉过敏启动

Wei-Shan Hsieh, Chia-Chi Kung, Shir-Ly Huang, Shih-Chang Lin, Wei-Hsin Sun